Thus, up-regulation of TDP-43 could be a therapeutic strategy for a wide range of human cancers in which NF-κB is constitutively activated [27,28] and is related to various oncogenic phenotypes, such as angiogenesis, tumor cell survival, cancer invasion and inflammation in tumor microenvironment [29]. The gene discussed is NFKB1; the disease is neoplasm.